CN Patent

CN118541156A — 马立巴韦用于治疗的用途及其治疗方案

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2024-08-23 · 2y expired

What this patent protects

马立巴韦的药物‑药物相互作用特性和药理特性的表征可用于告知当与联合用药一起施用时的潜在药物‑药物相互作用和给药策略。

USPTO Abstract

马立巴韦的药物‑药物相互作用特性和药理特性的表征可用于告知当与联合用药一起施用时的潜在药物‑药物相互作用和给药策略。

Drugs covered by this patent

Patent Metadata

Patent number
CN118541156A
Jurisdiction
CN
Classification
—
Expires
2024-08-23
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.